MAP3K20 and invasive breast carcinoma: With regard to clinical implications, analyzes on The Cancer Genome Atlas (TCGA) database and tissue microarray (TMA) showed that ZAK overexpression is associated with poor overall survival, especially for breast invasive carcinoma patients.